# METHOCARBAMOL
> **ANDA205404** · Abbreviated New Drug Application (Generic) · Sponsor: SAGENT PHARMS INC · Approved 2017-07-18
## Drug
- **FDA Application Number:** ANDA205404
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** METHOCARBAMOL
- **Generic name:** METHOCARBAMOL
- **Active ingredients:** METHOCARBAMOL
- **Dosage form:** SOLUTION
- **Route:** IM-IV
- **Marketing status:** Prescription
- **Sponsor:** SAGENT PHARMS INC
- **Manufacturer:** Sagent Pharmaceuticals
- **First approval:** 2017-07-18
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205404)
---
*MORVS · CC0 1.0*